Welcome to our dedicated page for Arteris SEC filings (Ticker: AIP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Arteris, Inc. filings document a semiconductor technology business built around System IP for SoC and chiplet design. Its 8-K reports cover quarterly and annual operating results, financial-condition updates, guidance exhibits, customer shipment milestones, royalty trends and product portfolio disclosures for network-on-chip interconnect IP, SoC integration automation software and hardware security assurance.
The company’s proxy materials cover board elections, executive compensation, equity incentive arrangements and stockholder voting matters. They also describe governance and business context for Arteris’ markets, including automotive, artificial intelligence and machine learning, 5G communications, data centers, edge computing, enterprise and consumer electronics.
Arteris, Inc. VP and Chief Financial Officer Nicholas B. Hawkins reported an open-market sale of 3,000 shares of common stock. The shares were sold at an average price of $37.7514 per share. After this transaction, he directly holds 108,549 shares of Arteris common stock.
A related footnote notes that this post-transaction amount includes 949 shares of common stock acquired on May 21, 2026 under the company’s Employee Stock Purchase Plan, highlighting ongoing participation in the issuer’s equity programs alongside the reported sale.
Arteris, Inc. director Wayne C. Cantwell reported an open-market sale of Common Stock through The Cantwell Living Trust on May 26, 2026. The trust sold 38,500 shares at a weighted average price of $37.2251 per share, in multiple trades between $36.79 and $37.55.
After the sale, The Cantwell Living Trust held 189,698 Arteris shares. Separate holding entries show Cantwell with 34,732 shares held directly and 38,761 shares held indirectly through the Decathlon Capital Management 401K Plan FBO Wayne Cantwell.
AIP reports a proposed sale of 3,000 shares of Common Stock. The filing lists the shares as purchased through an Employee Stock Purchase Plan on 11/11/2024 and offered for cash through Morgan Stanley Smith Barney LLC. The notice also discloses two recent dispositions: 221,035 shares sold on 05/15/2026 for $7,381,773.27 and 4,870 shares sold on 04/02/2026 for $85,969.13.
Arteris, Inc. director, President and CEO K. Charles Janac reported an insider transaction involving a bona fide gift of common stock by an entity he manages. Bayview Legacy, LLC, for which he serves as manager, made a gift transfer of 50,000 shares of Common Stock at a stated price of $0.00 per share. After this gift, Bayview Legacy, LLC is shown as beneficially owning 8,999,071 shares of Common Stock, over which Janac is deemed to have voting and dispositive power.
The filing also lists additional holdings as of the same date: 196,729 shares of Common Stock held directly by Janac and 56,252 shares held indirectly through the Charles and Lydia Janac Trust, for which he serves as trustee. The reported transaction is a non-market, non-cash gift rather than an open-market purchase or sale, so it primarily reflects personal or estate-planning activity rather than a change in market view.
Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported a bona fide gift of 50,000 shares of Common Stock on May 18, 2026 at a stated price of $0.00 per share. This is a non-market transfer classified as a gift rather than a sale.
After the transaction, Bayview Legacy, LLC indirectly holds 8,999,071 Arteris shares. Footnotes state that K. Charles Janac controls Bayview Legacy, LLC as its manager and is deemed to have voting and dispositive power over these shares.
Arteris, Inc. VP and Chief Financial Officer Nicholas B. Hawkins reported an exercise-and-sell sequence in company stock. On May 15, 2026, he exercised stock options covering 213,021 shares of common stock at exercise prices of $0.56 and $9.28 per share.
On the same date, he sold 221,035 shares of common stock in open-market transactions at weighted average prices ranging from about $32.18 to $34.65 per share, according to the footnotes. After these trades, he continues to hold more than 100,000 shares directly.
AIP: Form 144 reporting proposed dispositions
Broker-dealer Morgan Stanley Smith Barney LLC submitted a Form 144 relating to AIP securities, listing a restricted stock vesting of 8,014 shares dated 04/01/2026 and exercises tied to 15,625 shares and 197,396 shares dated 05/15/2026. The filing also reports a sale by Nicholas Hawkins of 4,870 shares on 04/02/2026 for $85,969.13.
Arteris, Inc. director Antonio J. Viana reported open-market sales of a total of 40,000 shares of common stock, primarily through the Viana Family Trust. The trust sold 15,538 shares at a weighted average price of $34.0595, 4,462 shares at $35.3534, and 20,000 shares at $38.00.
Following these transactions, the Viana Family Trust held 64,620 shares indirectly, while Viana also held 20,840 shares directly. The filing states that the sales were made under a Rule 10b5-1 trading plan adopted on June 10, 2025, and notes that some shares were sold in multiple trades at prices ranging from $34.00 to $35.43.
AIP notice of proposed sale: a filer submitted a Form 144 disclosing proposed sale of 40,839 shares of Common Stock, with the filing date 05/14/2026. The excerpt also lists four prior 10b5-1 transactions: 20,000 shares on 04/17/2026, 20,000 on 04/24/2026, 20,000 on 05/05/2026, and 20,000 on 05/13/2026, each showing aggregate values in the excerpt.